Compared with receiving chemotherapy alone, women with breast cancer who also received the hormonal drug triptorelin to achieve ovarian suppression had a higher long-term probability of ovarian function recovery, without a statistically significant difference in pregnancy rate or disease-free survival, according to a study published in JAMA. The majority of young women with invasive breast cancer … Continue reading Long-term outcomes of preventing premature menopause during chemotherapy
The anti-hormone therapy tamoxifen can reduce breast cancer recurrence by about half in women with hormone-sensitive breast cancer. But it works better in some women than others. Researchers are not sure why. "We do know that some tumors are inherently resistant to tamoxifen because of tumor genetic changes," says Daniel L. Hertz, Pharm.D., Ph.D., an … Continue reading Why does tamoxifen work better in some women?
Thyroid cancer survivors report poor quality of life after diagnosis and treatment compared with other patients who are diagnosed with more lethal cancers, according to new research from the University of Chicago Medicine. The findings, published in the journal Thyroid, shed light on a rarely studied outcome for a growing group of patients who are expected … Continue reading Thyroid cancer patients report poor quality of life despite ‘good’ diagnosis